Show simple item record

dc.contributor.authorMartin, AR
dc.contributor.authorWilliams, E
dc.contributor.authorFoulger, RE
dc.contributor.authorLeigh, S
dc.contributor.authorDaugherty, LC
dc.contributor.authorNiblock, O
dc.contributor.authorLeong, IUS
dc.contributor.authorSmith, KR
dc.contributor.authorGerasimenko, O
dc.contributor.authorHaraldsdottir, E
dc.contributor.authorThomas, E
dc.contributor.authorScott, RH
dc.contributor.authorBaple, E
dc.contributor.authorTucci, A
dc.contributor.authorBrittain, H
dc.contributor.authorde Burca, A
dc.contributor.authorIbanez, K
dc.contributor.authorKasperaviciute, D
dc.contributor.authorSmedley, D
dc.contributor.authorCaulfield, M
dc.contributor.authorRendon, A
dc.contributor.authorMcDonagh, EM
dc.date.accessioned2020-07-01T11:39:10Z
dc.date.available2020-07-01T11:39:10Z
dc.date.issued2019-11-01
dc.identifier.citationMartin, A.R., Williams, E., Foulger, R.E. et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet 51, 1560–1565 (2019). https://doi.org/10.1038/s41588-019-0528-2en_US
dc.identifier.issn1061-4036
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/65367
dc.description.abstractI ndividual genomes contain millions of genetic variants. When considering which variants may be causative for a given rare genetic disease, applying filtering criteria (such as allele frequency, predicted variant consequence, familial segregation and mode of inheritance) decreases this number to hundreds of variants. However, such a number remains labor intensive for a diagnostic genetic testing laboratory to interpret as part of routine service for each patient or family. A list of genes with evidence of disease causation in the condition being assessed aids in prioritizing and ranking the variants. This prioritization decreases the number of candidates that laboratories or clinical geneticists must assess to identify the likely causative variants for clinical reporting. Established lists of genes with clear evidence of disease causation (referred to herein as virtual gene panels) are therefore a highly effective tool in variant prioritization.en_US
dc.description.sponsorshipM. Caulfield was funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Center at Barts and The London School of Medicine and Dentistry. He is supported as an NIHR senior investigator, and this work was funded by the MRC eMedLab award. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health). The 100,000 Genomes Project is funded by the NIHR and NHSE. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructureen_US
dc.format.extent1560 - +
dc.language.isoenen_US
dc.publisherNature Research (part of Springer Nature)en_US
dc.relation.ispartofNATURE GENETICS
dc.subjectPanelAppen_US
dc.subjectdiagnostic gene panelsen_US
dc.subjectrare-disease diagnosticsen_US
dc.titlePanelApp crowdsources expert knowledge to establish consensus diagnostic gene panelsen_US
dc.typeArticleen_US
dc.rights.holder2019. The authors
dc.identifier.doi10.1038/s41588-019-0528-2
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494714300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue11en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume51en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record